109
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Understanding cytoskeleton regulators in glioblastoma multiforme for therapy design

, , , , , , , & show all
Pages 2881-2897 | Published online: 12 Sep 2016

References

  • Network TCCorrigendum: comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature20134947438506
  • Cancer Genome Atlas Research NetworkComprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature200845572161061106818772890
  • LouisDNOhgakiHWiestlerODThe 2007 WHO classification of tumours of the central nervous systemActa Neuropathol200711429710917618441
  • DolecekTAProppJMStroupNEKruchkoCCBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009Neuro Oncol201214suppl 5v1v4923095881
  • OikeTSuzukiYSugawaraKRadiotherapy plus concomitant adjuvant temozolomide for glioblastoma: Japanese mono-institutional resultsPLoS One2013811e7894324265731
  • StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
  • StuppRHegiMEMasonWPEuropean Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology GroupsNational Cancer Institute of Canada Clinical Trials GroupEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialLancet Oncol200910545946619269895
  • PeignanLGarridoWSeguraRCombined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitroNeurochem Res20113681397140621544552
  • ParsonsDWJonesSZhangXAn integrated genomic analysis of human glioblastoma multiformeScience200832158971807181218772396
  • KitambiSSToledoEMUsoskinDVulnerability of glioblastoma cells to catastrophic vacuolization and death induced by a small moleculeCell2014157231332824656405
  • DohertyGJMcMahonHTMediation, modulation, and consequences of membrane-cytoskeleton interactionsAnnu Rev Biophys200837659518573073
  • YilmazMChristoforiGEMT, the cytoskeleton, and cancer cell invasionCancer Metastasis Rev2009281–2153319169796
  • EvansSMJudyKDDunphyIHypoxia is important in the biology and aggression of human glial brain tumorsClin Cancer Res200410248177818415623592
  • JensenRLHypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measuresNeurosurg Focus2006204E2416709030
  • ZhouJSchmidTSchnitzerSBruneBTumor hypoxia and cancer progressionCancer Lett20062371102116002209
  • WangLZhaoKRenBExpression of cortactin in human gliomas and its effect on migration and invasion of glioma cellsOncol Rep20153441815182426238396
  • ZhangSQiQMTSS1 suppresses cell migration and invasion by targeting CTTN in glioblastomaJ Neurooncol2015121342543125385572
  • Fortin EnsignSPMathewsITSymonsMHBerensMETranNLImplications of Rho GTPase signaling in glioma cell invasion and tumor progressionFront Oncol2013324124109588
  • KatsetosCDDraberovaESmejkalovaBClass III beta-tubulin and gamma-tubulin are co-expressed and form complexes in human glioblastoma cellsNeurochem Res20073281387139817406983
  • OehlerCFreiKRushingEJPatupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trialOncology20128311922688083
  • BrennanCWVerhaakRGMcKennaAThe somatic genomic landscape of glioblastomaCell2013155246247724120142
  • ZarkoobHTaubeJHSinghSKManiSAKohandelMInvestigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface proteinPLoS One201385e6416923734191
  • NogueiraLRuiz-OntanonPVazquez-BarqueroABlockade of the NFkappaB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivoOncogene201130323537354821423202
  • GaoJAksoyBADogrusozUIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalSci Signal20136269pl123550210
  • CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
  • XuYYGaoPSunYDuanYRDevelopment of targeted therapies in treatment of glioblastomaCancer Biol Med201512322323726487967
  • SelmansbergerMKaiserJCHessJDose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomasCarcinogenesis201536774875625957251
  • RakRHaklaiRElad-TzfadiaGWolfsonHJCarmeliSKloogYNovel LIMK2 Inhibitor Blocks Panc-1 Tumor Growth in a mouse xenograft modelOncoscience201411394825593987
  • ThiyagarajanVTsaiMJWengCFAntroquinonol targets FAK-signaling pathway suppressed cell migration, invasion, and tumor growth of C6 gliomaPLoS One20151010e014128526517117
  • Escudero-EsparzaAJiangWGMartinTAClaudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathwaysJ Exp Clin Cancer Res2012314322559840
  • HegiMEDiserensACGorliaTMGMT gene silencing and benefit from temozolomide in glioblastomaN Engl J Med200535210997100315758010
  • BrandesAABassoUReniMFirst-line chemotherapy with cisplatin plus fractionated temozolomide in recurrent glioblastoma multiforme: a phase II study of the Gruppo Italiano Cooperativo di Neuro-OncologiaJ Clin Oncol20042291598160415117981
  • BruceJNFineRLCanollPRegression of recurrent malignant gliomas with convection-enhanced delivery of topotecanNeurosurgery201169612721279 discussion 1279–128021562434
  • KaiserSMullerJJFroehlichPEBaggio GnoattoSCBergoldAMFrom bacteria to antineoplastic: epothilones a successful historyAnticancer Agents Med Chem20131371057106823343081
  • BoiardiASilvaniAEoliMTreatment of recurrent glioblastoma: can local delivery of mitoxantrone improve survival?J Neurooncol200888110511318283418
  • SunXLiDYangYMicrotubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivityJ Pathol2012226466667321989536
  • WangCCLiauJYLuYSChenJWYaoYTLienHCDifferential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transitionHistopathology2012611788722439598
  • WuMLiuDYYuanXRThe expression of moesin in astrocytoma: correlation with pathologic grade and poor clinical outcomeMed Oncol201330137223315217
  • Van AelstLJonesonTBar-SagiDIdentification of a novel Rac1-interacting protein involved in membrane rufflingEMBO J19961515377837868670882
  • D’Souza-SchoreyCBoshansRLMcDonoughMStahlPDVan AelstLA role for POR1, a Rac1-interacting protein, in ARF6-mediated cytoskeletal rearrangementsEMBO J19971617544554549312003
  • DanieleTDi TullioGSantoroMTuracchioGDe MatteisMAARAP1 regulates EGF receptor trafficking and signallingTraffic20089122221223518764928
  • Aranda-OrgillesBAignerJKunathMLurzRSchneiderRSchweigerSActive transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2APLoS One2008310e350718949047